PKY

PATHKEYAI FPO [PKY]
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.0380 +2.7%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when PKY triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track PKY — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Took a hit — down 11.6% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.71, underperforming its peers
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Trading above the 200-day average — the long-term trend is on your side
  • Low cash runway (2 quarters) - dilution risk
  • Very high P/S ratio (162.7x)
  • Revenue in sharp decline (-75%)
  • Small-cap ($20-100M)
  • Capital raise activity (3 events)
  • Dilution velocity warning (3 raises recently)
  • CANSLIM S: Tight float (20%)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 143% over the past year (excluding last month)
  • The bigger volume days are the up days — volume-weighted momentum is positive (5.47%/day)
  • Altman Z-Score distress zone (1.74 < 1.81, low-confidence approx)
  • Elevated dilution risk (3 recent capital raises)
  • Low-priced stock risk ($0.038)
  • RBA hiking (-3pts)
  • Calendar: Quarterly Activities in 11d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -75% — the top line is shrinking
Ask Scout AI about PKY
"What's driving PKY today?" "How does PKY compare to peers?" "Key risks for PKY?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Cleansing Notice
NONE Proposed issue of securities - PKY
NONE Application for quotation of securities - PKY

Recent ASX Announcements

2026-07-10 Cleansing Notice
2026-07-10 Proposed issue of securities - PKY
2026-07-10 Application for quotation of securities - PKY
2026-06-30 Cleansing Notice
2026-06-30 Application for quotation of securities - PKY

Key Metrics

$47.2M
Market Cap
7.2M
Avg Volume
1.2x
Vol Ratio
$0.01 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-1344.9%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 20%
LLeader vs LaggardlaggardRS: -4
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:PKY vs IDTPKY vs ADRPKY vs LDX
Scout Pro — Deeper Analysis for PKY
Try Pro free for 30 days
Share this analysis

Track PKY and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required